ScreenerHero
BNNBRAIN Biotech AG
XETRA · DE · Healthcare · Specialty Chemicals · brain-biotech.com
2.830EUR-0.35%Mkt Cap: 67.20M $P/E: —

BRAIN Biotech AG provides bio-based products and solutions in Germany, the United States, France, the Netherlands, and the United Kingdom. The company operates through two segments: BRAINBiocatalysts and BRAINBioIncubato…

Industry Peers

Specialty Chemicals
Screen all
LIN
Linde plc
$221.79BUSDP/E 31.0
AI
L'Air Liquide S.A.
$116.02BUSDP/E 30.2
SHW
The Sherwin-Williams Company
$84.22BUSDP/E 31.9
ECL
Ecolab Inc.
$78.91BUSDP/E 37.8
APD
Air Products and Chemicals, Inc.
$67.52BUSD
GIVN
Givaudan SA
$34.34BUSDP/E 31.7
SIKA
Sika AG
$33.68BUSDP/E 28.4
DSFIR
DSM FIRMENICH AG
$24.08BUSDP/E 63.3
PPG
PPG Industries, Inc.
$25.32BUSDP/E 16.3
EMSN
EMS-CHEMIE HOLDING AG
$20.55BUSDP/E 38.6
LYB
LyondellBasell Industries NV
$21.34BUSD
IFF
International Flavors & Fragrances Inc.
$21.27BUSD
DD
DuPont de Nemours, Inc.
$18.86BUSDP/E 59.9
ALB
Albemarle Corporation
$15.84BUSDP/E 497.0
SY1
Symrise AG
$13.30BUSDP/E 50.4
RPM
RPM International Inc.
$14.25BUSDP/E 21.6
AKZA
AKZO NOBEL
$11.23BUSDP/E 16.2
BNR
Brenntag SE
$9.56BUSDP/E 24.2
WLK
Westlake Corporation
$10.15BUSD
EVK
Evonik Industries AG
$9.35BUSDP/E 71.0

Key Statistics

Company
Market Cap67.20M $
Enterprise Value70.17M $
Revenue (TTM)52.51M $
Gross Profit31.13M $
Net Income (TTM)-12.76M $
Revenue/Share2.403 USD
Last Price2.830 EUR
Fiscal Year EndSep 2025
MR QuarterMar 2026
Employees280
CountryDE
SectorHealthcare
IndustrySpecialty Chemicals
ISINDE0005203947
Valuation
P/E (Trailing)—
P/E (Forward)-7.17
PEG—
EV/EBITDA-15.08
EV/Revenue1.34
P/S1.28
P/B-15.99
EPS (TTM)-0.51
EPS (Forward)-0.39
52W Range
1.96049% of range3.740
52W High3.740 EUR
52W Low1.960 EUR
Profitability
Gross Margin57.26%
Oper. Margin-18.08%
EBITDA Margin-8.86%
Profit Margin-23.48%
ROE-637.81%
ROA-17.70%
Growth
Revenue Growth-5.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-10.04M $
CapEx (TTM)1.75M $
FCF Margin-22.75%
FCF Yield-17.77%
Net Debt2.96M $
Net Debt/EBITDA-0.64
Balance Sheet
Debt/Equity4.64
Current Ratio1.44
Quick Ratio0.74
Book Value/Sh-0.1770 EUR
Cash/Share0.1950 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)5.500 EUR
Upside (mean)+94.3%
Target Range5.000 EUR – 6.500 EUR
€5.000+94.3% to mean€6.500
# Analysts3
Ownership
Shares Out.21.85M
Float9.09M
Insiders58.36%
Institutions8.49%
Technical
SMA 502.835 (-0.2%)
SMA 2002.697 (+4.9%)
Beta0.63
S&P 52W Chg18.16%
Avg Vol (30d)2.64K
Avg Vol (10d)545
Technical Indicators
RSI (14)49.7
MACD0.0022
MACD Signal-0.0022
MACD Hist.+0.0044
BB Upper2.923 EUR
BB Middle2.818 EUR
BB Lower2.714 EUR
BB Width7.43%
ATR (14)0.1181 EUR
Vol Ratio (20d)0.14x